---
document_datetime: 2023-09-21 19:27:16
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/nplate-epar-all-authorised-presentations_en.pdf
document_name: nplate-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.5172291
conversion_datetime: 2025-12-19 00:06:00.606818
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## MA (EU) number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Content (concentration) Pack size

| EU/1/08/497/001   | Nplate   | 250 mcg   | Powder for solution for injection             | Subcutaneous use   |                                                           | powder: 250 mcg (500 mcg/mL)                  | 1 vial                                                                                                   |
|-------------------|----------|-----------|-----------------------------------------------|--------------------|-----------------------------------------------------------|-----------------------------------------------|----------------------------------------------------------------------------------------------------------|
| EU/1/08/497/002   | Nplate   | 500 mcg   | Powder for solution for injection             | Subcutaneous use   | vial (glass)                                              | powder: 500 mcg (500 mcg/mL)                  | 1 vial                                                                                                   |
| EU/1/08/497/003   | Nplate   | 250 mcg   | Powder for solution for injection             | Subcutaneous use   | vial (glass)                                              | powder: 250 mcg (500 mcg/mL)                  | 4 vials                                                                                                  |
| EU/1/08/497/004   | Nplate   | 500 mcg   | Powder for solution for injection             | Subcutaneous use   | vial (glass)                                              | powder: 500 mcg (500 mcg/mL)                  | 4 vials                                                                                                  |
| EU/1/08/497/005   | Nplate   | 250 mcg   | Powder and solvent for solution for injection | Subcutaneous use   | powder: vial (glass); solvent: pre-filled syringe (glass) | powder: 250 mcg (500 mcg/mL) solvent: 0.72 mL | 1 vial + 1 pre-filled syringe + 1 vial adapter + 1 needle + 1 syringe + 4 alcohol pads                   |
| EU/1/08/497/006   | Nplate   | 250 mcg   | Powder and solvent for solution for injection | Subcutaneous use   | powder: vial (glass); solvent: pre-filled syringe (glass) | powder: 250 mcg (500 mcg/mL) solvent: 0.72 mL | 4 x (1 vial + 1 pre-filled syringe + 1 vial adapter + 1 needle + 1 syringe + 4 alcohol pads) (multipack) |
| EU/1/08/497/007   | Nplate   | 500 mcg   | Powder and solvent for solution for injection | Subcutaneous use   | powder: vial (glass); solvent: pre-filled syringe (glass) | powder: 500 mcg (500 mcg/mL) solvent: 1.2 mL  | 1 vial + 1 pre-filled syringe + 1 vial adapter + 1 needle + 1 syringe + 4 alcohol pads                   |
| EU/1/08/497/008   | Nplate   | 500 mcg   | Powder and solvent for solution for injection | Subcutaneous use   | powder: vial (glass); solvent: pre-filled syringe (glass) | powder: 500 mcg (500 mcg/mL) solvent: 1.2 mL  | 4 x (1 vial + 1 pre-filled syringe + 1 vial adapter + 1 needle + 1 syringe + 4 alcohol pads) (multipack) |
| EU/1/08/497/009   | Nplate   | 125 mcg   | Powder for solution for injection             | Subcutaneous use   | vial (glass)                                              | powder: 125 mcg (500 mcg/mL)                  | 1 vial                                                                                                   |
| EU/1/08/497/010   | Nplate   | 125 mcg   | Powder for solution for injection             | Subcutaneous use   | vial (glass)                                              | powder: 125 mcg (500 mcg/mL)                  | 4 vials                                                                                                  |